GLENMARK PHARMA share price has plunged 14% and is presently trading at Rs 198.
Meanwhile, the BSE HEALTHCARE Index is at 11,870 (down 7.8%).
Among the top losers in the BSE HEALTHCARE Index today are GLENMARK PHARMA (down 13.8%) and DR. LAL PATHLABS LTD (down 10.2%).
Over the last one year, GLENMARK PHARMA has moved down from Rs 634 to Rs 198, registering a loss of Rs 436 (down 68.8%)..
The BSE HEALTHCARE has moved down from 14,333 to 11,870, loss of 2,463 points (down 17.2%) during the last 12 months.
The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 70.0%), J.B.CHEMICALS (up 41.1%) and DR. LAL PATHLABS LTD (up 37.1%).
Revealed: 3 Stocks for Potentially Massive Gains
The BSE Sensex is at 31,221 (down 9.4%).
In the meantime, NSE Nifty is at 9,133 (down 10.1%).
Over the last 12 months, the BSE Sensex has moved down from 37,536 to 31,221, registering a loss of 6,315 points (down 20.91%).
GLENMARK PHARMA net profit stood at Rs 2 billion for the quarter ended December 2019, compared to a profit of Rs 1 billion a year ago. Net Sales rose 7.1% to Rs 27.4 billion during the period as against Rs 25.6 billion in October-December 2018.
For the year ended March 2019, GLENMARK PHARMA reported 5.7% decrease in net profit to Rs 7.6 billion compared to net profit of Rs 8.0 billion during FY18.
Revenue of the company grew 8.4% to Rs 99 billion during FY19.
The current Price to earnings ratio of GLENMARK PHARMA, based on rolling 12 month earnings, stands at 6.8x. p >
What else is happening in the markets today? Dig in...
The SGX Nifty opened on a negative note today. At 8:10 am, it was trading down by 238 points, or 1.6% lower at 14,630 levels.
Top cues to track in today's stock market session.
View More Indian Share Market NewsIn this video, I'll tell you why I am recommending caution in the market at this time.
A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
In this video I'll show you exactly how I go about picking stocks for trading.
100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
More
Equitymaster requests your view! Post a comment on "GLENMARK PHARMA Plunges by 14%; BSE HEALTHCARE Index Down 7.8%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!